24小时热门版块排行榜    

查看: 618  |  回复: 4
【奖励】 本帖被评价4次,作者fishhope增加金币 3.2

fishhope

铁杆木虫 (正式写手)


[资源] 《化学前沿》2012年4月(英文版)-THOMSON REUTERS

IN THIS ISSUE
1 ORGA NIC SYNTHESIS SCHEME SHOWCASE
In this report, we look at a breakthrough chemoenzymatic approach that shows promise for a
more efficient route to synthesize ultra low molecular weight heparins.
4 SCAFFOLDS ON THE MOVE
Dihydronaphthyridinediones could represent a novel structural class of potent and selective
phosphodiesterase PDE7 inhibitors for the treatment of cognitive disorders. Also showcased are
antimalarial agents, oncolytic drugs, and drugs to combat HIV.
8 NEW MOLECULAR MECHANISMS OF ACTION
Hydroxyacid oxidase 2 (HAOX2, HAO2) inhibitors, integrin alphaMbeta2 (MAC-1) agonists
and histone acetyltransferase (HAT) activators, among a range of fascinating compounds, are
showcased in this issue.
9 THE START ING LINE
A selection of new molecular entities ready to progress in the R&D arena including
pharmacological activity, originator, and chemical structure.
12 NEW DRUGS FOR OLD
The search for new drugs is an increasingly costly business. With patents expiring and pipelines
drying up it is possible that the pharmaceutical industry is truly at the end of the so-called era
of blockbusters. In this article, we look at how the industry is finding ways to reformulate and
repurpose old products to new diseases and extracting novel applications for known agents.
回复此楼

» 本帖附件资源列表

  • 欢迎监督和反馈:小木虫仅提供交流平台,不对该内容负责。
    本内容由用户自主发布,如果其内容涉及到知识产权问题,其责任在于用户本人,如对版权有异议,请联系邮箱:xiaomuchong@tal.com
  • 附件 1 : CuttingEdgeOfChemistry-2012-April.pdf
  • 2014-02-27 07:52:23, 406.16 K

» 收录本帖的淘帖专辑推荐

信息调研

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

1949stone

荣誉版主 (知名作家)


★★★★★ 五星级,优秀推荐

★★★★★ 五星级
2楼2014-02-27 08:24:36
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
简单回复
2014-02-27 08:33   回复  
五星好评  顶一下,感谢分享!
kuanghua4楼
2014-03-01 08:54   回复  
五星好评  顶一下,感谢分享!
200025045楼
2015-07-29 12:48   回复  
五星好评  顶一下,感谢分享!
相关版块跳转 我要订阅楼主 fishhope 的主题更新
☆ 无星级 ★ 一星级 ★★★ 三星级 ★★★★★ 五星级
普通表情 高级回复 (可上传附件)
信息提示
请填处理意见